Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.
Share Price & News
How has Virtus Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: VRT is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: VRT's weekly volatility (4%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: VRT exceeded the Australian Healthcare industry which returned 23.6% over the past year.
Return vs Market: VRT exceeded the Australian Market which returned 27% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Virtus Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall StVirtus Health Limited's (ASX:VRT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
3 months ago | Simply Wall StSlowing Rates Of Return At Virtus Health (ASX:VRT) Leave Little Room For Excitement
4 months ago | Simply Wall StIs Now An Opportune Moment To Examine Virtus Health Limited (ASX:VRT)?
Virtus Health Fundamentals Summary
|VRT fundamental statistics|
Is VRT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|VRT income statement (TTM)|
|Cost of Revenue||AU$210.23m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.54|
|Net Profit Margin||12.92%|
How did VRT perform over the long term?See historical performance and comparison
4.1%Current Dividend Yield
Does VRT pay a reliable dividends?See VRT dividend history and benchmarks
|Virtus Health dividend dates|
|Ex Dividend Date||Oct 08 2021|
|Dividend Pay Date||Oct 29 2021|
|Days until Ex dividend||19 days|
|Days until Dividend pay date||40 days|
Does VRT pay a reliable dividends?See VRT dividend history and benchmarks
Is Virtus Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: VRT (A$5.92) is trading below our estimate of fair value (A$14.12)
Significantly Below Fair Value: VRT is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: VRT is good value based on its PE Ratio (11.7x) compared to the Australian Healthcare industry average (26.5x).
PE vs Market: VRT is good value based on its PE Ratio (11.7x) compared to the Australian market (18.7x).
Price to Earnings Growth Ratio
PEG Ratio: VRT is poor value based on its PEG Ratio (77.6x)
Price to Book Ratio
PB vs Industry: VRT is good value based on its PB Ratio (1.7x) compared to the AU Healthcare industry average (2.4x).
How is Virtus Health forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VRT's forecast earnings growth (0.2% per year) is below the savings rate (1.9%).
Earnings vs Market: VRT's earnings (0.2% per year) are forecast to grow slower than the Australian market (11.5% per year).
High Growth Earnings: VRT's earnings are forecast to grow, but not significantly.
Revenue vs Market: VRT's revenue (3.8% per year) is forecast to grow slower than the Australian market (5.3% per year).
High Growth Revenue: VRT's revenue (3.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: VRT's Return on Equity is forecast to be low in 3 years time (12.2%).
How has Virtus Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VRT has high quality earnings.
Growing Profit Margin: VRT's current net profit margins (12.9%) are higher than last year (0.2%).
Past Earnings Growth Analysis
Earnings Trend: VRT's earnings have declined by 8.5% per year over the past 5 years.
Accelerating Growth: VRT's earnings growth over the past year (9097.2%) exceeds its 5-year average (-8.5% per year).
Earnings vs Industry: VRT earnings growth over the past year (9097.2%) exceeded the Healthcare industry 61.3%.
Return on Equity
High ROE: VRT's Return on Equity (14.6%) is considered low.
How is Virtus Health's financial position?
Financial Position Analysis
Short Term Liabilities: VRT's short term assets (A$55.0M) do not cover its short term liabilities (A$79.3M).
Long Term Liabilities: VRT's short term assets (A$55.0M) do not cover its long term liabilities (A$225.4M).
Debt to Equity History and Analysis
Debt Level: VRT's debt to equity ratio (48.9%) is considered high.
Reducing Debt: VRT's debt to equity ratio has reduced from 49.8% to 48.9% over the past 5 years.
Debt Coverage: VRT's debt is well covered by operating cash flow (44.7%).
Interest Coverage: VRT's interest payments on its debt are well covered by EBIT (7.5x coverage).
What is Virtus Health current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: VRT's dividend (4.05%) is higher than the bottom 25% of dividend payers in the Australian market (2.3%).
High Dividend: VRT's dividend (4.05%) is low compared to the top 25% of dividend payers in the Australian market (5.41%).
Stability and Growth of Payments
Stable Dividend: VRT has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: VRT has only been paying a dividend for 8 years, and since then payments have not increased.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (44.6%), VRT's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: VRT's dividends in 3 years are forecast to be covered by earnings (61.2% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ms. Kathryn Marian Munnings, also known as Kate, serves as Group Chief Executive Officer, Managing Director and Executive Director at Virtus Health Limited since March 18, 2020. She serves as Director of D...
CEO Compensation Analysis
Compensation vs Market: Kate's total compensation ($USD1.17M) is above average for companies of similar size in the Australian market ($USD722.58K).
Compensation vs Earnings: Kate's compensation has increased by more than 20% in the past year.
Experienced Management: VRT's management team is considered experienced (2.7 years average tenure).
Experienced Board: VRT's board of directors are considered experienced (3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.7%.
Virtus Health Limited's company bio, employee growth, exchange listings and data sources
- Name: Virtus Health Limited
- Ticker: VRT
- Exchange: ASX
- Founded: 2008
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: AU$504.742m
- Shares outstanding: 85.26m
- Website: https://www.virtushealth.com.au
Number of Employees
- Virtus Health Limited
- 176 Pacific Highway
- Level 3
- New South Wales
Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore. The company operates through two segments, Healthcare Services Australia and He...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/18 08:03|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.